Dermapharm Holding SE (CHIX:DMPD) Marketable Securities: €28 Mil (As of Mar. 2026)


CHIX:DMPD Dermapharm Holding SE CHIX:DMPD
80 GF Score
Price €46.18
GF Value €39.39
! 9 Warning Signs
View Full Analysis

What is Dermapharm Holding SE Marketable Securities?

Dermapharm Holding SE CHIX:DMPD 80 Marketable Securities is €28 Mil as of Mar. 2026. GuruFocus rates CHIX:DMPD with a GF Score™ of 80/100 and a GF Value™ of €39.39. The stock has 9 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Dermapharm Holding SE's Marketable Securities for the quarter that ended in Mar. 2026 was €28 Mil.

Dermapharm Holding SE's annual Marketable Securities declined from Dec. 2023 (€1 Mil) to Dec. 2024 (€1 Mil) but then increased from Dec. 2024 (€1 Mil) to Dec. 2025 (€1 Mil).

Dermapharm Holding SE  (CHIX:DMPd) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Dermapharm Holding SE Marketable Securities Related Terms

Dermapharm Holding SE Marketable Securities Historical Data

* Premium members only.

The historical data trend for Dermapharm Holding SE's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dermapharm Holding SE Marketable Securities Chart

Dermapharm Holding SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.74 11.44 0.78 0.51 0.74

Dermapharm Holding SE Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.84 3.21 3.35 0.74 28.06
CHIX:DMPD
80GF Score
Dermapharm Holding SE CHIX:DMPD
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dermapharm Holding SE Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of €28 Mil mean?
Dermapharm Holding SE (CHIX:DMPD) has a Marketable Securities of €28 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Dermapharm Holding SE and its competitors.
Is Dermapharm Holding SE's Marketable Securities too high?
Dermapharm Holding SE's current Marketable Securities is €28 Mil. Overall, Dermapharm Holding SE has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Dermapharm Holding SE's Marketable Securities compare to ZTS and UTHR?
Dermapharm Holding SE's Marketable Securities of €28 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Dermapharm Holding SE and its competitors. Dermapharm Holding SE's current Marketable Securities is €28 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dermapharm Holding SE stock overvalued right now?
Dermapharm Holding SE (CHIX:DMPD) has a current Marketable Securities of €28 Mil. The stock's GF Value™ is €39.39, compared to a current price of €46.18 — trading 17.2% above its estimated fair value. The current Marketable Securities is €28 Mil. Dermapharm Holding SE's overall GF Score™ is 80/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Dermapharm Holding SE (CHIX:DMPD), the current Marketable Securities is €28 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dermapharm Holding SE (CHIX:DMPD) Overvalued in 2026?

Based on GuruFocus' analysis, Dermapharm Holding SE stock appears to be overvalued. The current stock price of €46.18 is trading 17.2% above its estimated GF Value™ of €39.39.

Key valuation signals for CHIX:DMPD:

  • Marketable Securities: €28 Mil
  • GF Value™: €39.39 vs. price of €46.18 (17.2% above fair value)
  • GF Score™: 80/100 with 9 warning signs

No single metric tells the full story. See the CHIX:DMPD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dermapharm Holding SE Business Description

Other Exchanges DMPHF:USA0A5J:UKDMP:Germany
Address Lil-Dagover-Ring 7, Grunwald, BY, DEU, 82031
Dermapharm Holding SE manufactures patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs, and natural remedies. The portfolio of the company includes cosmetics, nutritional supplements, and diet and medical devices. Business operating segments include Branded pharmaceuticals, which drive key revenue, Other healthcare products, and Parallel import business. The Branded pharmaceuticals segment covers numerous product areas through a wide variety of items sold under reputable brand names.
80GF Score

Get the complete analysis for CHIX:DMPD

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€46.18
Price
€39.39
GF Value